Over 100 industry representatives from different sectors (omics & single cell technologies, pharma, biotech, imaging, IT/data science, medical diagnostics) are invited to contribute to define the LifeTime industry strategy and innovation framework. We aim to identify new collaboration platforms for efficient paths towards the development of new products and services and their adoption into daily use in medicine, healthcare and the life sciences